Kewalramani Reshma
SEC insider (Form 3/4/5 filer). CIK 0001735944. CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX). 30 reported Form 4/5 transactions since Sep 2024; latest on Feb 27, 2026. Located in BOSTON, MA.
Companies Kewalramani Reshma has filed insider reports for
- VERTEX PHARMACEUTICALS INC / MA (VRTX): Director, Officer, CEO & President
Kewalramani Reshma
CIK: 0001735944
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VERTEX PHARMACEUTICALS INC / MA
Discretionary Trading P&L
Holdings
Transaction History (30 total)
- Feb 27, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect949 shares at avg. $491.30$466K - Feb 27, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect2.5K shares at avg. $493.29$1.2M - Feb 27, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect460 shares at avg. $489.32$225K - Feb 27, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect2.7K shares at avg. $490.54$1.3M - Feb 27, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect400 shares at avg. $479.75$192K - Feb 27, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect2.5K shares at avg. $487.13$1.2M - Feb 27, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect120 shares at avg. $481.50$58K - Feb 27, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect3.3K shares at avg. $488.27$1.6M - Feb 27, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect240 shares at avg. $482.84$116K - Feb 27, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect3.5K shares at avg. $494.33$1.7M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 949 | $491.30 | $466,244 | Direct |
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 2,520 | $493.29 | $1,243,091 | Direct |
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 460 | $489.32 | $225,087 | Direct |
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 2,725 | $490.54 | $1,336,722 | Direct |
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 400 | $479.75 | $191,900 | Direct |
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 2,510 | $487.13 | $1,222,696 | Direct |
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 120 | $481.50 | $57,780 | Direct |
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 3,278 | $488.27 | $1,600,549 | Direct |
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 240 | $482.84 | $115,882 | Direct |
| Feb 27, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 3,498 | $494.33 | $1,729,166 | Direct |
1-10 of 30 transactions